ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $714 | -24.7% | 26,600 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $948 | -52.5% | 26,600 | -66.2% | 0.00% | +33.3% |
Q1 2023 | $1,995 | +44.3% | 78,600 | +130.5% | 0.00% | -50.0% |
Q4 2022 | $1,383 | -99.9% | 34,100 | 0.0% | 0.01% | +20.0% |
Q3 2022 | $1,127,000 | -21.4% | 34,100 | -16.2% | 0.01% | -16.7% |
Q2 2022 | $1,433,000 | -21.1% | 40,700 | +3.0% | 0.01% | -14.3% |
Q1 2022 | $1,816,000 | -17.7% | 39,500 | +18.6% | 0.01% | -12.5% |
Q4 2021 | $2,207,000 | +12.9% | 33,300 | +6.4% | 0.01% | +14.3% |
Q3 2021 | $1,954,000 | -25.1% | 31,300 | -0.6% | 0.01% | -22.2% |
Q2 2021 | $2,608,000 | +46.3% | 31,500 | +17.1% | 0.01% | +28.6% |
Q1 2021 | $1,783,000 | -9.2% | 26,900 | +5.1% | 0.01% | -12.5% |
Q4 2020 | $1,964,000 | +104.6% | 25,600 | +14.8% | 0.01% | +100.0% |
Q3 2020 | $960,000 | -31.8% | 22,300 | -31.6% | 0.00% | -33.3% |
Q2 2020 | $1,407,000 | +31.5% | 32,600 | -12.4% | 0.01% | 0.0% |
Q1 2020 | $1,070,000 | -48.1% | 37,200 | +14.5% | 0.01% | -33.3% |
Q4 2019 | $2,061,000 | -14.1% | 32,500 | -61.9% | 0.01% | +80.0% |
Q3 2019 | $2,400,000 | +243.3% | 85,200 | +222.7% | 0.01% | +66.7% |
Q2 2019 | $699,000 | +202.6% | 26,400 | +109.5% | 0.00% | +200.0% |
Q1 2019 | $231,000 | – | 12,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |